As of May 2022 DexCom has a market cap of $31.35 Billion. This makes DexCom the world's 543th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $32.84 B | -36.88% |
2021 | $52.04 B | 46.58% |
2020 | $35.50 B | 77.19% |
2019 | $20.03 B | 85.83% |
2018 | $10.78 B | 116.19% |
2017 | $4.98 B | -1.16% |
2016 | $5.04 B | -24.59% |
2015 | $6.69 B | 57.24% |
2014 | $4.25 B | 65.76% |
2013 | $2.56 B | 171.81% |
2012 | $0.94 B | 50.27% |
2011 | $0.62 B | -25.83% |
2010 | $0.84 B | 128.04% |
2009 | $0.37 B | 351.42% |
2008 | $0.08 B | -67.43% |
2007 | $0.25 B | 1.78% |
2006 | $0.24 B | -33.91% |
2005 | $0.37 B |
On May 19th, 2022 the market cap of DexCom was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $460.04 B | 1,367.22% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | $196.77 B | 527.56% | ๐บ๐ธ USA |
![]() Medtronic MDT | $136.52 B | 335.43% | ๐ฎ๐ช Ireland |
![]() Becton Dickinson BDX | $71.93 B | 129.41% | ๐บ๐ธ USA |
![]() Edwards Lifesciences EW | $58.33 B | 86.06% | ๐บ๐ธ USA |
![]() Tandem Diabetes Care
TNDM | $4.60 B | -85.33% | ๐บ๐ธ USA |
![]() Quidel
QDEL | $4.15 B | -86.75% | ๐บ๐ธ USA |
![]() West Pharmaceutical WST | $22.20 B | -29.19% | ๐บ๐ธ USA |